Amphastar Pharmaceuticals, Inc. (AMPH)

NMS – Real Time Price. Currency in USD

17.50

-0.95 (-5.15%)

At close: May 12, 2026, 4:00 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

720M

732M

644M

499M

Cost of goods sold

-378M

-371M

-300M

-260M

Gross Profit

341M

361M

344M

239M

Operating expenses (excl. COGS)

-201M

-156M

-144M

-131M

Operating Income

140M

205M

200M

107M

Non-operating income, total

-17M

-16M

-28M

Pretax income

124M

190M

171M

116M

Equity in earnings

-573K

-2M

-1M

Taxes

-26M

-30M

-32M

-23M

Non-controlling/minority interest

After tax other income/expense

Net income before discontinued operations

98M

160M

138M

91M

Amphastar Pharmaceuticals, Inc. (AMPH)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Amphastar Pharmaceuticals, Inc. (AMPH)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Amphastar Pharmaceuticals, Inc. (AMPH)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Amphastar Pharmaceuticals, Inc. (AMPH)

Income Statement (Annual)

Income Statement (Annual)